Dear reader, in 2006, a developmental biologist at the University of California, Irvine, named Bruce Blumberg, proposed, with his colleague Felix Grün, a term that many of their colleagues found uncomfortable. He called certain industrial chemicals obesogens, arguing that they do not merely accompany obesity but help produce it, acting directly on the cellular machinery that decides how the body stores fat.
The compound that led him there was tributyltin, used for decades as a biocide in antifouling paints applied to ship hulls to prevent barnacles from growing, and prohibited worldwide in antifouling paints since 2008 under the International Maritime Organization's anti-fouling convention. His group found that it activates two receptors, RXR and PPAR gamma, which pair up to form the master switch that turns a precursor cell into a fat cell. Exposure did not simply make animals heavier. It appeared to recruit more fat cells permanently, and in some experiments the effect persisted into a third generation of offspring that had never encountered the chemical themselves.
His own summary of the finding is the part non-specialists remember: mice exposed to tributyltin do not eat more, and they do not exercise less. They simply carry more fat. If that is true, then the calorie ledger, intake on one side and expenditure on the other, is not the whole equation. Something is changing the exchange rate.
Now, let me be careful, because this idea is easily abused. Doses in many animal studies exceed typical human exposures, and the human evidence is largely observational, which makes exposure very hard to disentangle from diet, income, and where a person lives. And the main drivers of the obesity epidemic are not in dispute: an energy-dense and relentlessly available food supply, engineered palatability, sedentary work, short sleep, and the collapse of walking as a way of getting anywhere. Anyone who tells you chemicals explain modern obesity is selling something. The serious claim is narrower: that a set of common exposures may shift where the body sets its defended weight, making the same diet produce different outcomes in two people.
The candidate list beyond tributyltin includes bisphenols from can linings and receipts, certain phthalates from soft plastics and fragrances, some pesticides, and the forever chemicals discussed in these pages before. Several are established endocrine disruptors on other grounds, which makes the metabolic hypothesis credible rather than speculative.
The most consequential part of the theory concerns timing. Endocrine-active compounds behave differently in a developing organism than in an adult, because development is a sequence of switches that are thrown once. Exposure in the womb or in infancy, at doses that are harmless later, may set the number of fat cells a person carries for life or the sensitivity of the systems regulating appetite. If that is right, some of what we treat as an adult lifestyle problem was decided before the patient could walk.
Why does this matter here more than most places? Because Saudi Arabia and the Gulf carry one of the highest obesity burdens in the world, it has arrived in roughly one generation. We also have a heavily packaged food supply, most of it imported, and much of it stored and transported in extreme heat, which accelerates the migration of plasticizers and additives from the container into the contents. There is scattered work on this in the region, but nothing systematic enough to tell us what our own exposures actually are. We treat obesity as if the only variables are the plate and the treadmill, and we have never checked the third.
There is an ethical dimension, too, which is why I am willing to write about a contested hypothesis at all. We speak about obesity in a moral register that we apply to almost no other condition. Patients are told, in effect, that their body is a verdict on their character. Yet if a measurable share of the variance is set by exposures they did not choose, at ages they cannot remember, then the moral framing is not merely unkind. It is wrong on the facts, and it directs our efforts toward exhortation rather than regulation, which is the only tool that works on exposure.
We are now treating this population with the most effective weight loss medicines ever developed, and I am glad they exist. But they act on appetite and satiety signaling, downstream of everything discussed here. Treating the symptom brilliantly while leaving the upstream unexamined is a familiar pattern in medicine, and it ends with a very large bill and an unresolved cause.
Finally, the calorie explanation is not wrong. It is incomplete. The missing part is not the patient's willpower. It is in the packaging, the paint, the dust, and the water, which is to say in decisions made by industries and regulators, and not by the person standing on the scale.